Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.

Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.

Côté HC, Raboud J, Bitnun A, Alimenti A, Money DM, Maan E, Costei A, Gadawski I, Diong C, Read S, Shen S, Harrigan PR, Burdge DR, King SM, Forbes JC.

J Infect Dis. 2008 Sep 15;198(6):851-9. doi: 10.1086/591253.

PMID:
18684095
2.

Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.

Poirier MC, Divi RL, Al-Harthi L, Olivero OA, Nguyen V, Walker B, Landay AL, Walker VE, Charurat M, Blattner WA; Women and Infants Transmission Study (WITS) Group.

J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):175-83.

PMID:
12794551
3.

Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir.

Divi RL, Walker VE, Wade NA, Nagashima K, Seilkop SK, Adams ME, Nesel CJ, O'Neill JP, Abrams EJ, Poirier MC.

AIDS. 2004 Apr 30;18(7):1013-21.

PMID:
15096804
4.

Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.

Gingelmaier A, Grubert TA, Kost BP, Setzer B, Lebrecht D, Mylonas I, Mueller-Hoecker J, Jeschke U, Hiedl S, Friese K, Walker UA.

Antivir Ther. 2009;14(3):331-8.

PMID:
19474467
5.

Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.

Feiterna-Sperling C, Weizsaecker K, Bührer C, Casteleyn S, Loui A, Schmitz T, Wahn V, Obladen M.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):43-51.

PMID:
17356471
6.

Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy.

Jitratkosol MH, Sattha B, Maan EJ, Gadawski I, Harrigan PR, Forbes JC, Alimenti A, van Schalkwyk J, Money DM, Côté HC; CIHR Emerging Team Grant on HIV Therapy and Aging (CARMA).

AIDS. 2012 Mar 27;26(6):675-83. doi: 10.1097/QAD.0b013e32835142eb.

PMID:
22436539
7.

Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.

Briand N, Le Coeur S, Traisathit P, Karnchanamayul V, Hansudewechakul R, Ngampiyasakul C, Bhakeecheep S, Ithisukanan J, Hongsiriwon S, McIntosh K, Lallemant M.

Pediatr Infect Dis J. 2006 Apr;25(4):325-32.

PMID:
16567984
8.

Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women.

European Collaborative Study.

J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):380-7.

PMID:
12640195
9.

Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.

Ekouevi DK, Touré R, Becquet R, Viho I, Sakarovitch C, Rouet F, Towne-Gold B, Fassinou P, Leroy V, Blanche S, Dabis F; Agence Nationale de Recherches Sur le SIDA 1201/1202 Ditrame Plus Study Group.

Pediatrics. 2006 Oct;118(4):e1071-7. Epub 2006 Sep 1.

10.

Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers.

Bunders MJ, Bekker V, Scherpbier HJ, Boer K, Godfried M, Kuijpers TW.

Acta Paediatr. 2005 Nov;94(11):1571-7.

PMID:
16303696
11.

Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.

Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC.

Pediatr Infect Dis J. 2003 Sep;22(9):782-9.

PMID:
14506368
12.

Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.

Hernàndez S, Morén C, López M, Coll O, Cardellach F, Gratacós E, Miró O, Garrabou G.

AIDS. 2012 Feb 20;26(4):419-28. doi: 10.1097/QAD.0b013e32834f3232.

PMID:
22156962
13.

Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.

Noguera A, Fortuny C, Muñoz-Almagro C, Sanchez E, Vilaseca MA, Artuch R, Pou J, Jimenez R.

Pediatrics. 2004 Nov;114(5):e598-603. Epub 2004 Oct 18.

PMID:
15492359
14.

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

Aldrovandi GM, Chu C, Shearer WT, Li D, Walter J, Thompson B, McIntosh K, Foca M, Meyer WA 3rd, Ha BF, Rich KC, Moye J Jr.

Pediatrics. 2009 Dec;124(6):e1189-97. doi: 10.1542/peds.2008-2771. Epub 2009 Nov 23.

15.

Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy.

Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, Pinti M, Cossarizza A, Shikuma C.

J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):370-4.

PMID:
12640193
16.

[Efficiency and side effects of antiretroviral treatment of HIV infected pregnant women].

Simon T, Funke AM, Hero B, Reiser-Hartwig S, Fuhrmann U.

Zentralbl Gynakol. 2002 Aug-Sep;124(8-9):413-7. German.

PMID:
12655470
17.

Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants.

Prasitwattanaseree S, Lallemant M, Costagliola D, Jourdain G, Mary JY.

Antivir Ther. 2004 Apr;9(2):179-85.

PMID:
15134179
18.

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG; Pediatric Spectrum of HIV Disease Consortium.

Pediatrics. 2007 Apr;119(4):e900-6. Epub 2007 Mar 12.

PMID:
17353299
19.

Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina.

Fiscus SA, Adimora AA, Funk ML, Schoenbach VJ, Tristram D, Lim W, McKinney R, Rupar D, Woods C, Wilfert C.

Pediatr Infect Dis J. 2002 Jul;21(7):664-8.

PMID:
12237600
20.

Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study.

Paul ME, Chantry CJ, Read JS, Frederick MM, Lu M, Pitt J, Turpin DB, Cooper ER, Handelsman EL.

Pediatr Infect Dis J. 2005 Jan;24(1):46-56.

PMID:
15665710

Supplemental Content

Support Center